Europe's spin-out firms need patient capital for deeptech boom
European academic spin-out companies attracted significant venture capital in 2026, but analysts suggest they require patient capital, customer obsession, and support for female founders to fully capitalize on the deeptech boom.
Academic spin-out companies in Europe have attracted substantial venture capital throughout 2026, with billions of euros flowing into businesses built on university research. These firms often focus on developing cutting-edge deep technologies.
Despite the strong investment, industry analysts emphasize that sustained growth for these deeptech ventures necessitates a shift towards more patient capital. Spin-outs need to prioritize customer needs and develop business models that can support long development cycles, a common characteristic of deep technology companies.
Experts point to areas for improvement within the European ecosystem. While funding is available, its structure may not always align with the long-term R&D timelines of spin-outs. Furthermore, fostering greater support for female founders is seen as crucial for unlocking the full potential of the deeptech sector.
In the highly competitive global deeptech landscape, European spin-outs must demonstrate clear customer value. Access to patient capital, which allows for extended research and development without immediate profit pressures, is identified as a key factor for these companies to succeed and harness the opportunities presented by deep technologies.